Systematic review and network meta-analysis of combination and monotherapy treatments in disease-modifying antirheumatic drug-experienced patients with rheumatoid arthritis: analysis of American College of Rheumatology criteria scores 20, 50, and 70

BACKGROUND: Biologic disease-modifying antirheumatic drugs (bDMARDs) extend the treatment choices for rheumatoid arthritis patients with suboptimal response or intolerance to conventional DMARDs. The objective of this systematic review and meta-analysis was to compare the relative efficacy of EU-lic...

Descripción completa

Detalles Bibliográficos
Autores principales: Orme, Michelle E, MacGilchrist, Katherine S, Mitchell, Stephen, Spurden, Dean, Bird, Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529627/
https://www.ncbi.nlm.nih.gov/pubmed/23269860
http://dx.doi.org/10.2147/BTT.S36707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529627/
https://www.ncbi.nlm.nih.gov/pubmed/23269860
http://dx.doi.org/10.2147/BTT.S36707

Ejemplares similares